(PharmaNewsWire.Com, January 13, 2018 ) The North America Antinuclear Antibody Test Market was worth USD 312.93 million in 2016 and expected to reach USD 553.96 million by 2021 at a CAGR of 12.10%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a persons autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.
Factors such as increase in prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, growing economies in this region and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.
North America Antinuclear Antibody Test Market Segmentation
Disease
Technique
Product
End-User
Geographically, North America market is segmented into
U.S.
Canada.
U.S. has the bigger share among these two and is also growing at a better rate.
Some of the major companies dominating the market, by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
